Long intergenic non-protein coding RNA 2211 (LINC02211)

Long intergenic non-protein coding RNA 2211 (**LINC02211**) is a human long non-coding RNA (lncRNA) classified within the intergenic lncRNA (lincRNA) group[1][3][5]. It is non-protein coding based on all major bioinformatic assessments and is annotated with the gene symbol **LINC02211** and the full name "long intergenic non-protein coding RNA 2211," located on chromosome 5 (5q, chr5:25297734-25311370, on the positive strand)[1]. LINC02211 does not encode for a protein, shows no coding potential in translated analyses, and is conserved at the transcript level but with no linked functional or disease-specific literature. No roles as a therapeutic target, disease biomarker, or drug mechanism have been described, and no clinical or experimental data currently highlight pathological associations or safety concerns[1][3][5]. Summary context: Unlike some well-studied lincRNAs (such as LINC00511 or LINC01116, which are implicated in cancer[2][4]), **LINC02211** has no characterized biological functions or disease associations to date. There is no evidence supporting its use as a therapeutic or diagnostic target, and it is not referenced in GWAS traits or any disease pathways in standard databases[7][1][5]. Its listing in reliable resources (LNCipedia, GeneCards, NCBI Gene) is consistent and not spurious or erroneous, but functional data is lacking.

Other names

ENSG00000245662ENST00000641091.1ENSG00000245662.3LINC02211:8

Not applicable; no drugs or targeted agents described